Some of medtech's most innovative technologies were on display at the Consumer Electronics Show (CES) in Las Vegas this week.

The global biosensors market is driven by rapid adoption in healthcare, biopharma, environmental monitoring, and industrial applications. Rising chronic disease prevalence, point-of-care diagnostics, ...

Abbott Diabetes Care's Freestyle Libre Flash Glucose Monitoring System has been approved by the FDA. As well as finally bringing the system, which is already available in 39 other countries, home to ...

Withings has partnered with Abbott's Lingo CGM to bring glucose monitoring to 15 million users starting Q1 2026 for metabolic ...

Supersapiens, the first direct-to-consumer energy management ecosystem, utilizes the Abbott Libre Sense Glucose Sport Biosensor, the first glucose sport biosensor designed specifically for athletic ...